Cart
sales@molnova.com
Dimenhydrinate
CAS No. 523-87-5
Dimenhydrinate( NSC 117855 | NSC-117855 | NSC117855 | Dimenhydrinate | Dramalen | Dramamin )
Catalog No. M14850 CAS No. 523-87-5
Dimenhydrinate is an anti-emetic and anti-histamine commonly available over-the-counter as a motion sickness remedy.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 48 | In Stock |
|
| 100MG | 29 | In Stock |
|
| 200MG | 41 | In Stock |
|
| 500MG | 65 | In Stock |
|
| 1G | 91 | In Stock |
|
Biological Information
-
Product NameDimenhydrinate
-
NoteResearch use only, not for human use.
-
Brief DescriptionDimenhydrinate is an anti-emetic and anti-histamine commonly available over-the-counter as a motion sickness remedy.
-
DescriptionDimenhydrinate is an anti-emetic and anti-histamine commonly available over-the-counter as a motion sickness remedy.
-
In Vitro——
-
In VivoAnimal Model:Male ICR mice (22-28 g)Dosage:3, 10, and 30 mg/kg Administration:IP; single dose Result:Significantly increased CPP scores (+105.4 s) compared to those of the vehicle-treated control group.
-
SynonymsNSC 117855 | NSC-117855 | NSC117855 | Dimenhydrinate | Dramalen | Dramamin
-
PathwayGPCR/G Protein
-
TargetHistamine Receptor
-
RecptorH1 receptor
-
Research AreaNeurological Disease
-
Indication——
Chemical Information
-
CAS Number523-87-5
-
Formula Weight469.96
-
Molecular FormulaC24H28ClN5O3
-
Purity>98% (HPLC)
-
SolubilityDMSO: 10 mM
-
SMILESO=C(N1C)N(C)C2=C(NC(Cl)=N2)C1=O.CN(C)CCOC(C3=CC=CC=C3)C4=CC=CC=C4
-
Chemical Name8-chloro-1,3-dimethyl-1H-purine-2,6(3H,7H)-dione compound with 2-(benzhydryloxy)-N,N-dimethylethanamine (1:1)
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Chen X, et al. Nucleic Acids Res. 2002, 30(1):412-5.
molnova catalog
related products
-
Levocetirizine Dihyd...
Levocetirizine Dihydrochloride (Xyzal Dihydrochloride) is a third-generation peripheral H1-receptor antagonist. Acting as an antihistaminic agent, it specifically targets the histamine H1-receptor.
-
Astemizole
Antihistamine drug now withdrawn from the market in many countries because of rare but potentially fatal side effects.
-
JNJ-5207852 dihydroc...
JNJ-5207852 is a novel, non-imidazole histamine H3 receptor antagonist, with high affinity at the rat (pKi=8.9) and human (pKi=9.24) H3 receptor. JNJ-5207852 is a potent dibasic amine antagonist that binds potently to rat H3 receptors (Ki=1.2?nm), and has good brain penetration. In ex vivo binding studies in mice, the compound had an ED50 of 0.13?mg?kg?1, subcutaneously.
